Strides Pharma Science Limited has allotted 7,500 equity shares with a face value of ₹10 each to an eligible employee. The allotment was made pursuant to the exercise of stock options under the Strides ESOP 2016 Plan.
The allotment was approved by the Board of Directors at a meeting held on October 29, 2026, which commenced at 16:45 hrs (IST) and concluded at 18:15 hrs (IST).
Consequently, the company's paid-up share capital has increased from ₹921,727,140 (consisting of 92,172,714 equity shares) to ₹921,802,140 (consisting of 92,180,214 equity shares).
The newly allotted shares will rank pari-passu with the existing equity shares of the company in all respects. The allotment is a compliance disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Additional Announcements:
The filing also confirms that this information will be made available on the company's website at www.strides.com.